Showing results (21-30 of 133) with videos related to
Sort By:
Pageof 14
Thyroid : Official Journal of the American Thyroid Association|May 17, 2024
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based StudyDebbie W Chen, Grant Carr, Francis P Worden, et al.Endocrine Oncology (Bristol, England)|October 23, 2025
Success of <sup>177</sup>Lu-DOTATATE therapy in a metastatic pituitary neuroendocrine tumorKatherine I Wolf, Zhonglin Lu, Elizabeth A Hesseltine, et al.Cancer Nursing|January 13, 2022
Assessing Physical and Cognitive Function in Individuals With Head and Neck Cancer: A Feasibility StudyMoira A Visovatti, Mi Sook Jung, Heidi Mason, et al.Thyroid : Official Journal of the American Thyroid Association|August 20, 2010
A phase II study of imatinib in patients with advanced anaplastic thyroid cancerHuan T Ha, Julia S Lee, Susan Urba, et al.Head & Neck|October 30, 2013
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329Binu Malhotra, James Moon, Omar Kucuk, et al.Expert Review of Anticancer Therapy|September 24, 2013
Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerJeffrey M Vainshtein, Vivian F Wu, Matthew E Spector, et al.Nuclear Medicine Communications|June 15, 2022
Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumorsKa Kit Wong, Kirk A Frey, Jeremy Niedbala, et al.Head & Neck|March 28, 2023
Impact of monoclonal antibody therapy for head and neck cancer on end-of-life care utilization and costsWilliam J Benjamin, Pratyusha Yalamanchi, Jeremy M G Taylor, et al.Endocrine-Related Cancer|January 12, 2026
Prevalence and Clinical Characteristics of Lynch Syndrome-associated Adrenocortical CarcinomaAvilasha Sinha, Katherine I Wolf, Jenae Osborne, et al.European Thyroid Journal|December 14, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancerAndrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, et al.Pageof 14